A 5 - [(1R) - 2 - ({2 - [4 - (2,2-di-di-phenyl) phenyl) ethyl) amino) - 1-hydroxymethyl ether] - 8-hydroxytoluene-2 (1H) - ona, and a dicarbonate, sulfur, or sulfur. There is also a drug synthesis, including salts, which may contain another therapeutic agent, such as corticosteroids, anti linear agents and / or PDE4 inhibitors, in which corticosteroids are insectivorous, budesonida, Trichlorobenzene, among others, the anti linear is hydroxyformate, ipsopropropi, Among other things, the relapse inhibitors and PDE4 inhibitors are benzofendine, aprofillin and loripram,There are others These compounds can be used to treat respiratory diseases caused by beta2 receptor activity.REFERIDA A UNA SAL DE ADICION CRISTALINA DE 5-[(1R)-2-({2-[4-(2,2-DIFLUORO-2-FENILETOXI)FENIL]ETIL}AMINO)-1-HIDROXIETIL]-8-HIDROXIQUINOLIN-2(1H)-ONA Y UN ACIDO DICARBOXILICO, SULFONICO O UNA SULFIMIDA DEL MISMO. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE A DICHA SAL Y PUEDE CONTENER OTRO AGENTE TERAPEUTICO TAL COMO UN CORTICOSTEROIDE, UN AGENTE ANTICOLINERGICO Y/O UN INHIBIDOR DE PDE4, DONDE EL CORTICOSTEROIDE ES PREDNISOLONA, BUDESONIDA, TRIAMCINOLONA, ENTRE OTROS, EL ANTICOLINERGICO ES SALES DE OXITROPIO, DE IPRATOPRIO, REVATROPATO, ENTRE OTROS Y EL INHIBIDOR DE PDE4 ES BENAFENTRINA, AROFILINA, ROLIPRAM, ENTRE OTROS. DICHOS COMPUESTOS SON UTILES EN EL TRATAMIENTO DE ENFERMEDADES RESPIRATORIAS ASOCIADAS A LA ACTIVIDAD DEL RECEPTOR ADRENERGICO BETA2
